BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16401498)

  • 1. Fecal occult blood testing options.
    Lastella VP
    Gastroenterology; 2006 Jan; 130(1):285; author reply 285. PubMed ID: 16401498
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 3. Offering patients colorectal cancer screening.
    Church TR
    J Natl Cancer Inst; 2005 Mar; 97(5):328-9. PubMed ID: 15741562
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Fletcher RH; Ransohoff DF; Imperiale TF
    Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
    [No Abstract]   [Full Text] [Related]  

  • 5. Colorectal cancer screening.
    Ederer F; Church T; Mandel J
    Scand J Gastroenterol; 2004 Oct; 39(10):1031-2; author reply 1029-30. PubMed ID: 15513349
    [No Abstract]   [Full Text] [Related]  

  • 6. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal neoplasia.
    Kronborg O
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):127-9. PubMed ID: 10363197
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

  • 10. "Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data." by Moayyedi P and Achkar E.
    Zappa M; Castiglione G; Grazzini G; Stefano C
    Am J Gastroenterol; 2006 Oct; 101(10):2433; author reply 2433-4. PubMed ID: 17032207
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening with a fecal multitarget DNA test.
    Young GP; Worthley DL
    Gastroenterology; 2005 Aug; 129(2):757-9; discussion 759. PubMed ID: 16083732
    [No Abstract]   [Full Text] [Related]  

  • 12. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
    Skitek M
    Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
    [No Abstract]   [Full Text] [Related]  

  • 13. Stool test for colorectal cancer screening--it's time to move!
    Loitsch SM; Shastri Y; Stein J
    Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of immunochemical faecal occult blood tests according to number of samples and positivity threshold.
    Guittet L; Launoy G
    J Med Screen; 2008; 15(1):48-9. PubMed ID: 18416958
    [No Abstract]   [Full Text] [Related]  

  • 16. Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT.
    Allison JE
    Gastroenterology; 2005 Aug; 129(2):745-8. PubMed ID: 16083728
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
    Corder AP; Iqbal M; Devaraj S
    Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
    [No Abstract]   [Full Text] [Related]  

  • 18. Does fecal occult blood test have a place for colorectal cancer screening in China in 2006?
    Sung J
    Am J Gastroenterol; 2006 Feb; 101(2):213-5. PubMed ID: 16454819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.